Evidence map›Paper›PMID 28806902›Full record

ArticleBMC infectious diseases2017

Monitoring, documenting and reporting the quality of antibiotic use in the Netherlands: a pilot study to establish a national antimicrobial stewardship registry.

Marvin Ah Berrevoets, Jaap Ten Oever, Tom Sprong, Reinier M van Hest, Ingeborg Groothuis, Inger van Heijl, Jeroen A Schouten, Marlies E Hulscher, Bart-Jan Kullberg

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Guidelines for the hospital role of the clinical nurse in antimicrobial stewardship: A scoping review.The Southern African journal of critical care : the official journal of the Critical Care Society · 2021
    Article
  8. Drug use evaluation (DUE) of ceftriaxone: A quality metric in a pediatric hospital.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2020
    Article
  9. Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Marvin Ah BerrevoetsDepartment of Internal Medicine, Division of Infectious Diseases, Radboud university medical center, Nijmegen, The Netherlands. marvin.berrevoets@radboudumc.nl.ORCID 0000-0001-8333-277X
Jaap Ten OeverDepartment of Internal Medicine, Division of Infectious Diseases, Radboud university medical center, Nijmegen, The Netherlands.
Tom SprongDepartment of Internal Medicine, Division of Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Reinier M van HestDepartment of Hospital Pharmacy & Clinical Pharmacology, Academic Medical Center, Amsterdam, The Netherlands.
Ingeborg GroothuisDepartment of Internal Medicine, Zuiderzee Medical Center, Lelystad, The Netherlands.
Inger van HeijlDepartment of Clinical Pharmacy, Tergooi Hospital, Hilversum, The Netherlands.
Jeroen A SchoutenScientific Institute for Quality of Healthcare, Radboud university medical center, Nijmegen, The Netherlands.
Marlies E HulscherScientific Institute for Quality of Healthcare, Radboud university medical center, Nijmegen, The Netherlands.
Bart-Jan KullbergDepartment of Internal Medicine, Division of Infectious Diseases, Radboud university medical center, Nijmegen, The Netherlands.
Radboud University Nijmegen · NLAmsterdam UMC Location University of Amsterdam · NLCanisius-Wilhelmina Ziekenhuis · NLTergooi · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Dutch Working Party on Antibiotic Policy is developing a national antimicrobial stewardship registry. This registry will report both the quality of antibiotic use in hospitals in the Netherlands and the stewardship activities employed. It is currently unclear which aspects of the quality of antibiotic use are monitored by antimicrobial stewardship teams (A-teams) and can be used as indicators for the stewardship registry. In this pilot study we aimed to determine which stewardship objectives are eligible for the envisioned registry.

methodsWe performed an observational pilot study among five Dutch hospitals. We assessed which of the 14 validated stewardship objectives (11 process of care recommendations and 3 structure of care recommendations) the A-teams monitored and documented in individual patients. They provided, where possible, data to compute quality indicator (QI) performance scores in line with recently developed QIs to measure appropriate antibiotic use in hospitalized adults for the period of January 2015 through December 2015

resultsAll hospitals had a local antibiotic guideline describing recommended antimicrobial use. All A-teams monitored the performance of bedside consultations in Staphylococcus aureus bacteremia and the prescription of restricted antimicrobials. Documentation and reporting were the best for the use of restricted antimicrobials: 80% of the A-teams could report data. Lack of time and the absence of an electronic medical record system enabling documentation during the daily work flow were the main barriers hindering documentation and reporting.

conclusionsFive out of 11 stewardship objectives were actively monitored by A-teams. Without extra effort, 4 A-teams could report on the quality of use of restricted antibiotics. Therefore, this aspect of antibiotic use should be the starting point of the national antimicrobial stewardship registry. Our registry is expected to become a powerful tool to evaluate progress and impact of antimicrobial stewardship programs in hospitals.

Indexed as

AdultAnti-Bacterial AgentsAnti-Infective AgentsBacteremiaHospitalsHumansNetherlandsPilot ProjectsRegistriesStaphylococcal InfectionsStaphylococcus aureusAnti-Bacterial AgentsAnti-Infective AgentsAntibiotic stewardshipAntimicrobial stewardship programAntimicrobial stewardship teamBenchmarkingQuality indicatorQuality of care

Identifiers

PMID28806902
PMCPMC5557571
OpenAlexW2747452768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.